We are live on ! Find out more
MJP

Michael J. Puzo Portfolio holdings

AUM $343M
1-Year Est. Return 18.42%
This Fund
S&P 500
This Quarter Est. Return
+2.66%
1 Year Est. Return
+18.42%
3 Year Est. Return
+60.27%
5 Year Est. Return
+82.68%
10 Year Est. Return
+283.93%
AUM
$236M
AUM Growth
+$1.42M
Cap. Flow
-$2.96M
Cap. Flow %
-1.25%
Top 10 Hldgs %
39.01%
Holding
79
New
Increased
18
Reduced
52
Closed
2

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$571K
2
ILMN icon
Illumina
ILMN
+$309K
3
MMM icon
3M
MMM
+$265K
4
FTV icon
Fortive
FTV
+$235K
5
GILD icon
Gilead Sciences
GILD
+$226K

Top Sells

Rank Stock Value
1
MA icon
Mastercard
MA
+$420K
2
JNJ icon
Johnson & Johnson
JNJ
+$420K
3
GE icon
GE Aerospace
GE
+$396K
4
ORCL icon
Oracle
ORCL
+$389K
5
INTC icon
Intel
INTC
+$359K

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Healthcare 22.93%
3 Industrials 14.15%
4 Financials 10.16%
5 Consumer Staples 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OZK icon
26
Bank OZK
OZK
$5.49B
$2.99M 1.27%
66,430
-3,025
-4% -$144K
EOG icon
27
EOG Resources
EOG
$78B
$2.98M 1.26%
23,998
+813
+4% +$94.4K
ILMN icon
28
Illumina
ILMN
$29.4B
$2.83M 1.2%
10,406
+1,216
+13% +$309K
XYL icon
29
Xylem
XYL
$28.5B
$2.56M 1.08%
37,910
-2,300
-6% -$167K
ORCL icon
30
Oracle
ORCL
$331B
$2.52M 1.07%
57,226
-8,450
-13% -$389K
PEP icon
31
PepsiCo
PEP
$186B
$2.48M 1.05%
22,787
-199
-0.9% -$20.6K
MRK icon
32
Merck
MRK
$324B
$1.81M 0.77%
31,337
-839
-3% -$47.3K
ABBV icon
33
AbbVie
ABBV
$458B
$1.64M 0.69%
17,676
-900
-5% -$87.9K
FTV icon
34
Fortive
FTV
$19B
$1.56M 0.66%
32,085
+4,929
+18% +$235K
GILD icon
35
Gilead Sciences
GILD
$161B
$1.49M 0.63%
20,998
+3,202
+18% +$226K
EMR icon
36
Emerson Electric
EMR
$82.9B
$1.37M 0.58%
19,814
-912
-4% -$64.1K
MKC icon
37
McCormick & Company Non-Voting
MKC
$13.4B
$1.37M 0.58%
23,540
+140
+0.6% +$7.35K
CELG
38
DELISTED
Celgene Corp
CELG
$1.35M 0.57%
16,973
+6,883
+68% +$571K
ESBA icon
39
Empire State Realty Series ES
ESBA
$1.49B
$1.34M 0.57%
78,573
-4,000
-5% -$67.3K
SJM icon
40
J.M. Smucker
SJM
$12.6B
$1.32M 0.56%
12,237
-500
-4% -$56.1K
V icon
41
Visa
V
$677B
$1.29M 0.55%
9,740
-640
-6% -$82.4K
RDS.A
42
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$1.11M 0.47%
16,100
VTI icon
43
Vanguard Total Stock Market ETF
VTI
$654B
$913K 0.39%
6,500
-200
-3% -$27.9K
BRK.B icon
44
Berkshire Hathaway Class B
BRK.B
$1.07T
$905K 0.38%
4,850
-300
-6% -$58.5K
SLB icon
45
SLB Ltd
SLB
$78.4B
$870K 0.37%
12,964
+661
+5% +$45.4K
BMY icon
46
Bristol-Myers Squibb
BMY
$127B
$828K 0.35%
14,960
-1,640
-10% -$88.6K
UNP icon
47
Union Pacific
UNP
$182B
$788K 0.33%
5,558
-42
-0.8% -$5.86K
CL icon
48
Colgate-Palmolive
CL
$72.6B
$718K 0.3%
11,072
-50
-0.4% -$3.27K
STT icon
49
State Street
STT
$50.9B
$628K 0.27%
6,749
-800
-11% -$79.3K
PFE icon
50
Pfizer
PFE
$140B
$595K 0.25%
17,273
-711
-4% -$24.3K

Similar funds

Michael J. Puzo's Q2 2018 Portfolio in Review

As of Q2 2018, Michael J. Puzo held 79 positions worth $236M, up 0.61% from $235M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Trading was light in Q2 2018: portfolio turnover was 2.5%. Michael J. Puzo opened no new positions and exited 2, leaving the 79-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Michael J. Puzo added most to Celgene Corp in Q2 2018, an estimated $571K increase.
  • Michael J. Puzo's biggest Q2 2018 reduction was Mastercard, cutting an estimated $420K.
  • Michael J. Puzo fully exited Eaton in Q2 2018, selling an estimated $272K.
  • Michael J. Puzo's ten largest holdings make up 39% of its $236M portfolio in Q2 2018.
  • Michael J. Puzo opened 0 new positions and closed 2 in Q2 2018.
  • Michael J. Puzo's portfolio value rose 0.61% quarter-over-quarter to $236M.

Based on Michael J. Puzo's 13F filing for Q2 2018, filed 30 Jul 2018.